Table 1.
No. of fractions | All | 1 | 3 | 5 |
---|---|---|---|---|
No. of lesions | 353 | 270 (76%) | 70 (20%) | 13 (4%) |
Median age, y (range) | 67.2 (20-89) | 67.9 (30-86) | 65.0 (20-87) | 61.8 (21-89) |
Sex | ||||
Male | 265 (75%) | 211 (78%) | 43 (61%) | 11 (85%) |
Female | 88 (25%) | 59 (22%) | 27 (39%) | 2 (15%) |
ECOG performance status | ||||
0 | 213 (60%) | 166 (61%) | 42 (60%) | 5 (38%) |
1 | 107 (30%) | 77 (29%) | 24 (34%) | 6 (46%) |
2 | 30 (8%) | 24 (9%) | 4 (6%) | 2 (15%) |
3 | 2 (1%) | 2 (1%) | 0 (0%) | 0 (0%) |
4 | 1 (0%) | 1 (0%) | 0 (0%) | 0 (0%) |
Bilsky grade | ||||
0 | 268 (76%) | 217 (80%) | 41 (59%) | 10 (77%) |
1 | 52 (15%) | 38 (14%) | 14 (20%) | 0 (0%) |
2 | 26 (7%) | 10 (4%) | 13 (19%) | 3 (23%) |
3 | 7 (2%) | 5 (2%) | 2 (3%) | 0 (0%) |
SINS category | ||||
≤6 | 214 (61%) | 173 (64%) | 34 (49%) | 7 (54%) |
≥7 | 139 (39%) | 97 (36%) | 36 (51%) | 6 (46%) |
Location of treatment | ||||
Cervical | 70 (19%) | 55 (20%) | 12 (17%) | 3 (23%) |
Cervical + thoracic | 3 (1%) | 1 (0%) | 2 (3%) | 0 (0%) |
Thoracic | 259 (71%) | 192 (71%) | 49 (70%) | 8 (62%) |
Thoracic + lumbar | 2 (1%) | 2 (1%) | 0 (0%) | 0 (0%) |
Lumbar | 29 (8%) | 20 (20%) | 7 (7%) | 2 (15%) |
No. of lesions treated | ||||
1 | 268 (76%) | 216 (80%) | 44 (63%) | 8 (62%) |
2 | 53 (15%) | 36 (13%) | 15 (21%) | 2 (15%) |
3 | 27 (8%) | 17 (6%) | 7 (10%) | 3 (23%) |
4 | 5 (1%) | 1 (0%) | 4 (6%) | 0 (0%) |
Primary tumor | ||||
Prostate | 150 (42%) | 136 (50%) | 14 (20%) | 0 (0%) |
Kidney | 56 (16%) | 40 (15%) | 14 (20%) | 2 (15%) |
Endometrial | 29 (8%) | 24 (9%) | 5 (7%) | 0 (0%) |
Sarcoma | 28 (8%) | 13 (5%) | 7 (10%) | 8 (62%) |
Lung | 27 (8%) | 16 (6%) | 11 (16%) | 0 (0%) |
Other | 63 (18%) | 41 (15%) | 19 (27%) | 3 (23%) |
Histology | ||||
Adenocarcinoma | 179 (51%) | 153 (57%) | 26 (37%) | 0 (0%) |
Other | 174 (49%) | 117 (43%) | 44 (63%) | 13 (100%) |
Abbreviations: ECOG = Eastern Cooperative Oncology Group; SINS = spinal instability neoplastic score.